Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Golan

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Harefuah|August 19, 2015
[FROM STATISTICAL ASSOCIATIONS TO SCIENTIFIC CAUSALITY]Daniel Golan, Shay Linn
Journal of Neurology|February 22, 2023
Safety of lumbar puncture for people who are treated with ADP receptor antagonistsMary Nash, Sivan Bloch, Daniel Golan
Current Opinion in Neurology|April 13, 2016
Shifting paradigms in multiple sclerosis: from disease-specific, through population-specific toward patient-specificDaniel Golan, Elsebeth Staun-Ram, Ariel Miller
Journal of Community Genetics|September 3, 2021
Diagnostic yield and recognized barriers of an adult neurogenetics clinicAmir Peleg, Lena Sagi-Dain, Daniel Golan
Military Medicine|March 16, 2007
Helicobacter pylori infection and seasickness susceptibility among naval sailors: is there any association?Daniel Golan, Alex Rosental, Esther Sobel, et al.
Scientific Reports|October 24, 2024
The prevalence of multiple sclerosis in Israel based on validation of a health care organization databaseMaha Hurani, Idit Lavi, Sivan Bloch, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 1, 2020
Mobile phone-based e-diary for assessment and enhancement of medications adherence among patients with multiple sclerosisDaniel Golan, Smadar Sagiv, Lea Glass-Marmor, et al.
Plos One|May 5, 2021
Mobile-phone-based e-diary derived patient reported outcomes: Association with clinical disease activity, psychological status and quality of life of patients with multiple sclerosisDaniel Golan, Smadar Sagiv, Lea Glass-Marmor, et al.
Journal of Neurology|August 17, 2023
Risk of breakthrough COVID-19 after vaccination among people with multiple sclerosis on disease-modifying therapiesRonen Spierer, Idit Lavi, Sivan Bloch, et al.
Journal of the Neurological Sciences|December 6, 2011
Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosisLena Melamud, Daniel Golan, Rafael Luboshitzky, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Harefuah|August 19, 2015
[FROM STATISTICAL ASSOCIATIONS TO SCIENTIFIC CAUSALITY]Daniel Golan, Shay Linn
Journal of Neurology|February 22, 2023
Safety of lumbar puncture for people who are treated with ADP receptor antagonistsMary Nash, Sivan Bloch, Daniel Golan
Current Opinion in Neurology|April 13, 2016
Shifting paradigms in multiple sclerosis: from disease-specific, through population-specific toward patient-specificDaniel Golan, Elsebeth Staun-Ram, Ariel Miller
Journal of Community Genetics|September 3, 2021
Diagnostic yield and recognized barriers of an adult neurogenetics clinicAmir Peleg, Lena Sagi-Dain, Daniel Golan
Military Medicine|March 16, 2007
Helicobacter pylori infection and seasickness susceptibility among naval sailors: is there any association?Daniel Golan, Alex Rosental, Esther Sobel, et al.
Scientific Reports|October 24, 2024
The prevalence of multiple sclerosis in Israel based on validation of a health care organization databaseMaha Hurani, Idit Lavi, Sivan Bloch, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 1, 2020
Mobile phone-based e-diary for assessment and enhancement of medications adherence among patients with multiple sclerosisDaniel Golan, Smadar Sagiv, Lea Glass-Marmor, et al.
Plos One|May 5, 2021
Mobile-phone-based e-diary derived patient reported outcomes: Association with clinical disease activity, psychological status and quality of life of patients with multiple sclerosisDaniel Golan, Smadar Sagiv, Lea Glass-Marmor, et al.
Journal of Neurology|August 17, 2023
Risk of breakthrough COVID-19 after vaccination among people with multiple sclerosis on disease-modifying therapiesRonen Spierer, Idit Lavi, Sivan Bloch, et al.
Journal of the Neurological Sciences|December 6, 2011
Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosisLena Melamud, Daniel Golan, Rafael Luboshitzky, et al.
Pageof 5